Takeda Pharmaceuticals America, Inc.

ADZYNMA

Manufacturer:

Takeda Pharmaceuticals America, Inc.

Adzynma HCPCS:

C9167

HCPCS Code Descriptor:

Injection, apadamtase alfa, 10 units

Category:

C Code

Adzynma NDCs:

64764-0145-05, 64764-0140-05

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Adzynma:

ADZYNMA is aligned to the C Code: C9167. ADZYNMA is a Hematology medication produced by Takeda Pharmaceuticals America, Inc. and administered via the Intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

C9167 Added Date:

4/1/24

C9167 Effective Date:

4/1/24

C9167 Deactive Date:

HCPCS Active

Adzynma billing and coding information can be found through Takeda Pharmaceuticals America, Inc. at the link below:
Adzynma patient assistance information can be found through Takeda Pharmaceuticals America, Inc. at the URL: https://www.hematologysupport.com/adzynma
ADZYNMA prescribing information can be found at the link below:
Our team has not yet identified a source of side effect information for ADZYNMA